A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO AND ACTIVE CONTROLLED, PARALLEL GROUP, DOSE FINDING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LCI699, A NEW EXPERIMENTAL ANTIHYPERTENSIVE DRUG, IN PATIENTS WITH ESSENTIAL HYPERTENSION: